Journal Information
Vol. 89. Issue 5.
Pages 515 (September - October 2013)
Share
Share
Download PDF
More article options
Vol. 89. Issue 5.
Pages 515 (September - October 2013)
Letter to the Editor
Open Access
Reply to “Reclassifying inflammatory bowel disease with capsule endoscopy in children”
Resposta à “Reclassificação da doença inflamatória intestinal com cápsula endoscópica em crianças”
Visits
3309
Ana Sant’Anna
Division of Gastroenterology and Nutrition, Department of Pediatrics, McGill University, Montreal Children's Hospital, Montreal, Canada
This item has received

Under a Creative Commons license
Article information
Full Text
Bibliography
Download PDF
Statistics
Full Text

In response to the letter to the editor by Joshi et al., we agree that the scoring system for the diagnosis of small bowel disease with capsule endoscopy (CE) using three or more ulcers is not ideal, as it doesn’t include tissue samples, but it has been accepted currently as a consensus.1 It was not initially reported by us, but none of the children were taking non-steroidal anti-inflammatory drugs (NSAIDs) at the time of the study, as we were aware of the possible mucosal breaks secondary to the use of NSAIDS.2

As stated in our article, all patients were investigated at their initial diagnosis of inflammatory bowel disease (IBD). It was not described in details; however, all patients were symptomatic (iron deficiency anemia, abdominal pain, diarrhea, blood in stools), justifying the investigation to rule out IBD. The capsule study was performed within three months of the initial investigations.

Regarding the management of patients after the capsule study, one patient was started on azathioprine early in the course of disease, one patient was started on budesonide, and one patient (negative study) was discontinued from mesalamine. It is important to reinforce that all patients were followed in the IBD clinic at the McMaster Children's Hospital for 12 months after the capsule study, confirming the diagnosis of Crohn's disease or ulcerative colitis, according to the findings of the CE studies.

We completely agree with the authors that CE is a novel tool3–6 in assessing IBDU and should be used with caution, as there is not yet a histological confirmation available with the CE study.

References
[1]
A. Bourreille, A. Ignjatovic, L. Aabakken, E.V. Loftus Jr., R. Eliakim, M. Pennazio, et al.
Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus.
Endoscopy, 41 (2009), pp. 618-637
[2]
J.L. Goldstein, G.M. Eisen, B. Lewis, I.M. Gralnek, S. Zlotnick, J.G. Fort, et al.
Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo.
Clin Gastroenterol Hepatol, 3 (2005), pp. 133-141
[3]
E.G. Seidman, A.M. Sant’Anna, M.H. Dirks.
Potential applications of wireless capsule endoscopy in the pediatric age group.
Gastrointest Endosc Clin N Am, 14 (2004), pp. 207-217
[4]
M. Thomson, A. Fritscher-Ravens, M. Mylonaki, P. Swain, M. Eltumi, R. Heuschkel, et al.
Wireless capsule endoscopy in children: a study to assess diagnostic yield in small bowel disease in paediatric patients.
J Pediatr Gastroenterol Nutr, 44 (2007), pp. 192-197
[5]
F. Argüelles-Arias, A. Caunedo, J. Romero, A. Sánchez, M. Rodríguez-Téllez, F.J. Pellicer, et al.
The value of capsule endoscopy in pediatric patients with a suspicion of Crohn's disease.
Endoscopy, 36 (2004), pp. 869-873
[6]
S.A. Cohen, I.M. Gralnek, H. Ephrath, L. Saripkin, W. Meyers, O. Sherrod, et al.
Capsule endoscopy may reclassify pediatric inflammatory bowel disease: a historical analysis.
J Pediatr Gastroenterol Nutr, 47 (2008), pp. 31-36

Please cite this article as: Sant’Anna A. Reply to “Reclassifying inflammatory bowel disease with capsule endoscopy in children”. J Pediatr (Rio J). 2013;89:515.

Copyright © 2013. Sociedade Brasileira de Pediatria
Download PDF
Idiomas
Jornal de Pediatria (English Edition)
Article options
Tools
en pt
Taxa de publicaçao Publication fee
Os artigos submetidos a partir de 1º de setembro de 2018, que forem aceitos para publicação no Jornal de Pediatria, estarão sujeitos a uma taxa para que tenham sua publicação garantida. O artigo aceito somente será publicado após a comprovação do pagamento da taxa de publicação. Ao submeterem o manuscrito a este jornal, os autores concordam com esses termos. A submissão dos manuscritos continua gratuita. Para mais informações, contate assessoria@jped.com.br. Articles submitted as of September 1, 2018, which are accepted for publication in the Jornal de Pediatria, will be subject to a fee to have their publication guaranteed. The accepted article will only be published after proof of the publication fee payment. By submitting the manuscript to this journal, the authors agree to these terms. Manuscript submission remains free of charge. For more information, contact assessoria@jped.com.br.
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.